🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main objectives of this large phase IIb/III paediatric study are to ass...
Status
Completed
Location
University of California Davis
Start Date
2013-09-25
Trial ID
NCT01895777
Treatments Being Tested
The goal of this clinical trial is to find out the clinical and cost effect...
Status
Recruiting
Location
Epsom and St Helier University Hospitals NHS Trust
Start Date
2024-11-12
Trial ID
NCT06370273
This is an event driven Phase 3, prospective, randomized, open-label, blind...
Status
Completed
Location
Banner University Medical Center
Start Date
2017-03-27
Trial ID
NCT02798471
Treatments Being Tested
The purpose of this study is to compare the safety of two different dose re...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00790907
Fondaparinux is an antithrombotic agent having already received a regulator...
Status
Completed
Location
GARANGER Thierry
Start Date
2007-06
Trial ID
NCT00555438
Treatments Being Tested
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are sudden an...
Status
Recruiting
Location
Department of Respiratory Medicine, University Hospital of Patras
Start Date
2026-01-25
Trial ID
NCT07299695
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of fondapa...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-12
Trial ID
NCT00843492
Treatments Being Tested
RATIONALE: Fondaparinux may help prevent blood clots from forming in patien...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2007-01
Trial ID
NCT00381888
Treatments Being Tested
To assess the safety and pharmacokinetics of DU-176b administered to patien...
Status
Completed
Location
Toyooka Chuo Hospital
Start Date
2012-03
Trial ID
NCT01857583
Treatments Being Tested
The purpose of this study is to evaluate comparative efficacy and safety of...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-13
Trial ID
NCT02234843
Treatments Being Tested